Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Entera Health
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Termination Agreement January 21, 2020
RedHill provided a notice of termination to Entera Health regarding the license agreement for EnteraGamÂ® and the co-promotion agreement with Advanz Pharma Corp. for DonnatalÂ® will not be renewed.